Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-095955
Filing Date
2020-04-02
Accepted
2020-04-02 16:06:04
Documents
12
Period of Report
2020-05-13
Effectiveness Date
2020-04-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A d902836ddef14a.htm DEF 14A 968545
2 GRAPHIC g902836g0327024411661.jpg GRAPHIC 2094
3 GRAPHIC g902836g0327024411973.jpg GRAPHIC 2693
4 GRAPHIC g902836g0327024412145.jpg GRAPHIC 2481
5 GRAPHIC g902836g0327024412332.jpg GRAPHIC 675
6 GRAPHIC g902836g0327024412535.jpg GRAPHIC 681
7 GRAPHIC g902836g0327024413736.jpg GRAPHIC 678
8 GRAPHIC g902836g0327024415359.jpg GRAPHIC 12006
9 GRAPHIC g902836g0327024415640.jpg GRAPHIC 27492
10 GRAPHIC g902836g0327024416139.jpg GRAPHIC 15532
11 GRAPHIC g902836page085.jpg GRAPHIC 82162
12 GRAPHIC g902836page086.jpg GRAPHIC 93022
  Complete submission text file 0001193125-20-095955.txt   1301172
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1225
Type: DEF 14A | Act: 34 | File No.: 001-35803 | Film No.: 20768961
SIC: 2834 Pharmaceutical Preparations